← Back to Search

Problem-Solving Therapy + BEACON App for Suicide Prevention

N/A
Waitlist Available
Led By Simon Hatcher, PhD
Research Sponsored by University of Ottawa
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Identifies as Male
18 years of age or older
Must not have
Identifies as female
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline; session 6; 3 months; 6 months post-enrollment
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing whether problem-solving therapy, supplemented by a smartphone app, is effective in treating men who present to the Emergency Department. 100 men will be enrolled and randomized to either receive face-to-face PST or face-to-face PST supplemented by the BEACON Suicide Prevention smartphone application.

Who is the study for?
This trial is for men over 18 who have self-harmed and visited an Emergency Department in Ontario within the last month. They must understand English, French, or Oji Cree, be willing to attend six therapy sessions using a smartphone app, return for follow-ups, and commit to a six-month study.
What is being tested?
The study tests problem-solving therapy (PST) with or without the BEACON Suicide Prevention app for men after self-harm. Participants will receive face-to-face PST (possibly via videoconference), use the app if assigned, and share their experiences through interviews.
What are the potential side effects?
While not explicitly listed in the provided information, potential side effects may include emotional discomfort or distress due to discussing sensitive topics during therapy sessions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I identify as male.
Select...
I am 18 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I identify as female.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline; session 6; 3 months; 6 months post-enrollment
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline; session 6; 3 months; 6 months post-enrollment for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Measure of Suicidality - 24-Item Beck Scale for Suicidal Ideation (BSS)
Secondary study objectives
Adherence to Masculine Gender Roles - 94-Item Conformity to Masculine Norms Scale (CMNI): Emotional Control Sub-Scale
Adherence to Masculine Gender Roles - 94-Item Conformity to Masculine Norms Scale (CMNI): Self-Reliance Sub-Scale
Change in Alcohol Misuse - 10-Item Alcohol Use Disorder Identification Test (AUDIT)
+17 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Blended-TherapyExperimental Treatment1 Intervention
Participants with receive six sessions of face-to-face PST supplemented by the BEACON platform.
Group II: PST AloneActive Control1 Intervention
Participants will receive six sessions of face-to-face PST.

Find a Location

Who is running the clinical trial?

University of OttawaLead Sponsor
221 Previous Clinical Trials
269,549 Total Patients Enrolled
Ottawa Hospital Research InstituteOTHER
575 Previous Clinical Trials
3,094,783 Total Patients Enrolled
Simon Hatcher, PhDPrincipal InvestigatorUniversity of Ottawa
~18 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top